Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 3/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 10/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.33 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.31 |
| ▸ | BRAF | P15056 | 2/20 | 0.31 |
| ▸ | AURKA | O14965 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25528922 | 0.91 | CACNA1H (0.35) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25529090 | 0.88 | ROCK2 (0.33) | CACNA1HROCK2ROCK1USP30CACNA1G | |
| SCHEMBL25528926 | 0.88 | ROCK2 (0.32) | CACNA1HROCK2ROCK1AURKA | |
| SCHEMBL25532518 | 0.87 | CACNA1H (0.36) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25528945 | 0.87 | CACNA1H (0.36) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25531285 | 0.87 | ROCK2 (0.33) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25531296 | 0.87 | ROCK2 (0.33) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25528621 | 0.87 | CACNA1H (0.36) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25528924 | 0.87 | CACNA1H (0.37) | CACNA1HROCK2ROCK1USP30AURKA | |
| SCHEMBL25528475 | 0.86 | CACNA1H (0.36) | CACNA1HROCK2ROCK1USP30AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023093787-A1 | BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR | 成都奥睿药业有限公司 | 2023-06-01 | — | — | WO | disclosed |